Literature DB >> 21608381

Trends in duration of hospitalization for patients with tuberculosis in Montreal, Canada from 1993 to 2007.

Kianoush Dehghani1, Robert Allard, Jean Gratton, Louise Marcotte, Paul Rivest.   

Abstract

OBJECTIVE: To study the trend of hospital stays for patients diagnosed with pulmonary TB in Montreal from 1993 to 2007.
METHODS: From the registry of hospital discharge summary information, we selected first hospitalizations for patients with a diagnosis of TB, and from the reportable diseases registry, patients with culture positive pulmonary TB. We linked the selected cases, using the first 3 characters of postal code of residence, sex and age. From the linked cases, we included those for whom date of patient's admission to hospital (from the former registry) was similar to the date of notification to the public health department (from the latter registry), while allowing for an appropriate variation.
RESULTS: Among the 563 linked cases, the median duration of hospitalization was 17.0 days. Duration of hospitalization did not significantly decrease during the study period. Cases with positive sputum smear were more likely to stay in hospital > or = 14 days compared to those without one (OR = 1.90, 95% CI: 1.34-2.70). TB cases > or = 50 years of age remained in hospital longer than those between 18-49 years of age (OR = 1.66, 95% CI: 1.15-2.40).
CONCLUSION: For 63.9% (360) of the cases studied, the duration of hospitalization was > or = 14 days, which is consistent with the minimum recommended hospital stay for patients with pulmonary TB in Canada. Further studies are necessary to examine the impact of discharging hospitalized TB patients before 14 days of hospital stay on the risk of TB transmission in the community.

Entities:  

Mesh:

Year:  2011        PMID: 21608381      PMCID: PMC6973685     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  6 in total

1.  Hospitalization of homeless persons with tuberculosis in the United States.

Authors:  S M Marks; Z Taylor; N R Burrows; M G Qayad; B Miller
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

2.  Use of geographic and genotyping tools to characterise tuberculosis transmission in Montreal.

Authors:  I Haase; S Olson; M A Behr; I Wanyeki; L Thibert; A Scott; A Zwerling; N Ross; P Brassard; D Menzies; K Schwartzman
Journal:  Int J Tuberc Lung Dis       Date:  2007-06       Impact factor: 2.373

3.  Costs for tuberculosis care in Canada.

Authors:  Dick Menzies; Megan Lewis; Olivia Oxlade
Journal:  Can J Public Health       Date:  2008 Sep-Oct

4.  Tuberculosis--a review of 498 recent admissions to hospital.

Authors:  R S Goldstein; M Contreras; G A Craig; O T Cheung
Journal:  Can Med Assoc J       Date:  1982-03-01       Impact factor: 8.262

5.  TUBERCULOSIS: HOSPITALIZATION AND OUTPATIENT TREATMENT.

Authors:  C A WICKS
Journal:  Can Med Assoc J       Date:  1964-08-22       Impact factor: 8.262

6.  Cost determinants of tuberculosis management in a low-prevalence country.

Authors:  M Bocchino; S Greco; Y Rosati; G Mattioli; A Marruchella; P De Mori; C Bibbolino; E Girardi; S Squarcione; C Saltini
Journal:  Int J Tuberc Lung Dis       Date:  2006-02       Impact factor: 2.373

  6 in total
  1 in total

Review 1.  Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence.

Authors:  Giovanni Battista Migliori; Dina Visca; Martin van den Boom; Simon Tiberi; Denise Rossato Silva; Rosella Centis; Lia D'Ambrosio; Tania Thomas; Emanuele Pontali; Laura Saderi; H Simon Schaaf; Giovanni Sotgiu
Journal:  Pulmonology       Date:  2021-01-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.